Abstract:Aneurysmal subarachnoid hemorrhage (SAH) causes high rates of mortality and morbidity. A covered stent is an effective endovascular treatment for complicated aneurysms intractable to endovascular coiling and surgical clipping. However, in-stent restenosis and delayed endothelialization are the main challenges contributing to its safety. In this study, we designed a biofunctional stent covered with dual drug-loaded electrospun fibers to achieve programmed vascular endothelial growth factor (VEGF) and paclitaxel (PTX) release for the early promotion of stent endothelialization and long-term inhibition of stenosis caused by smooth muscle hyperplasia. By encapsulating PTX-loaded mesoporous silica nanoparticles (MSNs) within electrospun polylactic acid (PLA) fibers, the release period of PTX was effectively extended. Furthermore, VEGF was conjugated onto the surface of the membrane by reacting with polydopamine (PDA) for quick release. The in vitro drug release profile revealed the sustained release of PTX, which persisted for 63 days without early burst release, while up to 87.05% of VEGF was rapidly released within 3 days. After 6 days of incubation, cell experiments demonstrated that the dual drug-loaded scaffold effectively prompted endothelial cell proliferation (488% vs. 386% in the control group, P = 0.001) and inhibited the proliferation of smooth muscle cells (SMCs) using the 21-day extracts (155% vs. 303% in the control group, P = 0.039). Animal studies showed that compared to bare stents, the drug-loaded covered stents improved the immediate- and mid-term complete aneurysm occlusion rates (P < 0.05). The drug-loaded covered stents also showed earlier endothelialization promotion and better lumen restenosis than normal covered stents (0% vs. 25%, P = 0.29) for 12 weeks. Overall, a programmed dual drug-loaded scaffold that effectively occluded the aneurysm sac was developed in this study, and the discrete release of VEGF and PTX promoted endothelialization and prevented in-stent stenosis. This study provided a new method to improve the biosafety of implanted covered stents for the treatment of intracranial aneurysms. STATEMENT OF SIGNIFICANCE: Aneurysmal subarachnoid hemorrhage (SAH) is one of the most common hemorrhage stroke resulted in a nearly 40% mortality and 33% morbidity due to sudden rupture of an intracranial aneurysm. Endovascular coil embolism is a popular treatment for aneurysm but this technique run high risk of bleeding, mass effect, low complete occlusion rate and higher recanalization rate due to its operation conducted within aneurysm sac. A bio-functional membrane knitted by dual-drug loaded electrospun fibers covered on a stent was designed to realize programed vascular endothelial growth factor and paclitaxel release for the early promotion of vascular endothelium and long-term inhibition of stenosis caused by smooth muscle hyperplasia. This study provides new method to improve the biosafety of covered stent insertion for the treatment of intracranial aneurysms.

An Electrospun Fiber-Covered Stent with Programmable Dual Drug Release for Endothelialization Acceleration and Lumen Stenosis Prevention.

Heparin and Vascular Endothelial Growth Factor Loaded Poly(L-lactide-co-caprolactone) Nanofiber Covered Stent-Graft for Aneurysm Treatment

An Atorvastatin Calcium and Poly(l-Lactide-co-caprolactone) Core-Shell Nanofiber-Covered Stent to Treat Aneurysms and Promote Reendothelialization

Atorvastatin Calcium and Poly(L-lactide-co-caprolactone) Core-Shell Nanofiber Covered Stent Separating Aneurysm and Promoting Endothelialization

A Novel Heparin Loaded Poly(l-Lactide-co-caprolactone) Covered Stent for Aneurysm Therapy

Heparin- and Rosuvastatin- loaded Poly(L-lactide-co-caprolactone) Nanofiber Aneurysm Covered Stent Inhibits Inflammatory Smooth Muscle Cell in Reducing in-stent Stenosis and Thrombosis

Bioinspired Vascular Stents with Microfluidic Electrospun Multilayer Coatings for Preventing in‐stent Restenosis

A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation

A bio-inspired nanoparticle coating for vascular healing and immunomodulatory by cGMP-PKG and NF-kappa B signaling pathways

Woven Vascular Stent-Grafts with Surface Modification of Silk Fibroin-Based Paclitaxel/Metformin Microspheres

Rosuvastatin- and Heparin-Loaded Poly(l-lactide- Co-Caprolactone) Nanofiber Aneurysm Stent Promotes Endothelialization Via Vascular Endothelial Growth Factor Type A Modulation.

Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.

Development of a novel endothelial cell-seeded endovascular stent for intracranial aneurysm therapy.

Comparison of Gelatin/Polylysine‐ and Silk Fibroin/SDF‐1α‐Coated Mesenchymal Stem cell‐Seeded Intracranial Stents

3D-Printed Bioresorbable Stent Coated with Dipyridamole-Loaded Nanofiber for Restenosis Prevention and Endothelialization

Surface modification with dopamine and heparin/poly-L-lysine nanoparticles provides a favorable release behavior for the healing of vascular stent lesions.

Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis

Reconstructive Endovascular Treatment of Intracranial Aneurysms with the Willis Covered Stent: Medium-Term Clinical and Angiographic Follow-Up.

Bioresorbable Electronic Stent Integrated with Therapeutic Nanoparticles for Endovascular Diseases

REDV/Rapamycin-loaded Polymer Combinations As a Coordinated Strategy to Enhance Endothelial Cells Selectivity for a Stent System.

Application of covered stents in the treatment of intracranial aneurysms